P2RX7 and neoplasm: Remarkably, the previous study has demonstrated that the ATP releasing by dying tumor cells would act on P2X7 purinergic receptors and subsequently trigger NLRP3-CASP1 complex (inflammasome) to mediate the innate and adaptive immune responses against dying tumor cells (Ghiringhelli et al., 2009).